Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Skin symptoms are important for diagnosing infections in children.

Cyclosporin doesn't stop hair loss.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Omeprazole effectively treats severe acid reflux in children for short-term use, but long-term safety needs more research.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.